LLLei Lan

Lei Lan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lei Lan has a total of 113 co-authors. Here are the top co-authors by number of shared publications:

  • Zhimin Yin

    Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, China

    9 shared publications
  • Lan Luo

    State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China

    7 shared publications
  • Lei Shen

    Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, Jiangsu, PR China

    7 shared publications
  • Fengyi Wan

    Department of Biochemistry and Molecular Biology Bloomberg School of Public Health, Johns Hopkins University Baltimore MD USA

    6 shared publications
  • Min Xu

    School of Life Sciences Nanjing Normal University Nanjing PR China

    5 shared publications
  • Zhilin Qi

    Jiangsu Province Key Laboratory for Molecular Biotechnology, College of Life Science, Nanjing Normal University, No. 1 Wenyuan Road, Nanjing 210046, PR China; Department of Biochemistry, Wannan Medical College, Wuhu, Anhui, PR China

    5 shared publications

Latest Publications

  • MrgprD ‐mediated macrophage polarization drives chemically induced colitis in mice

    by Yiping Lv, Lili Xia, Zhao Qiao, Tiantian Li, Min Xu, Meng Kong, Zongxiang Tang, Fengyi Wan, Lei Lan

    Inflammatory bowel disease (IBD) is characterized by aberrant immune responses in the gut. Mas‐related G protein‐coupled receptor D (MrgprD), which is primarily expressed in sensory neurons of the dorsal root ganglia (DRG), is known to promote neuroinflammation. However, its potential role in driving intestinal inflammation remains undefined. Here, we show that systemic Mrgprd KO alleviated dextran sodium sulfate (DSS)‐induced acute colitis. We found that MrgprD was expressed in colonic macrophages and DSS treatment increased its expression. Mrgprd global deletion reduced macrophage infiltration in the colon and suppressed their pro‐inflammatory M1 polarization following DSS challenge. Using conditional KO mouse lines, we further demonstrate that myeloid‐specific Mrgprd deletion conferred stronger protection than its neuronal deletion. This is evidenced by preserved colon length, reduced histopathology scores, improved barrier integrity, and decreased M1 macrophage proportions. Notably, neuron‐specific, but not myeloid‐specific, Mrgprd KO accelerated intestinal motility under physiological conditions. MrgprD deficiency reduced M1‐associated gene expression and suppressed NF‐κB signaling activation in both colonic lamina propria cells and bone marrow‐derived macrophages (BMDMs), whereas activation of MrgprD by its agonist enhanced these responses in BMDMs. Bioinformatic analysis further supports the involvement of the MRGPRD‐NF‐κB signaling axis in human IBD. Collectively, our findings identify MrgprD as a novel driver of acute colitis, acting primarily through NF‐κB‐mediated pro‐inflammatory macrophage polarization in the colon. © 2026 The Pathological Society of Great Britain and Ireland.


  • TRPA1 protects mice from pathogenic Citrobacter rodentium infection via maintaining the colonic epithelial barrier function

    by Lin Liu, Min Xu, Zhudi Zhang, Zhao Qiao, Zongxiang Tang, Fengyi Wan, Lei Lan

    Transient receptor potential ankyrin 1 (TRPA1) is expressed in gastrointestinal tract and plays important roles in intestinal motility and visceral hypersensitivity. However, the potential role of TRPA1 in host defense, particularly against intestinal pathogens, is unknown. Here, we show that Trpa1 knockout mice exhibited increased susceptibility to Citrobacter rodentium infection, associated with the increased severity of diarrhea and intestinal permeability associated with the disrupted tight junctions (TJs) in colonic epithelia. We further demonstrated the expression of TRPA1 in murine colonic epithelial cells (CECs) and human epithelial Caco‐2 cells both at protein level and transcription level. Using calcium imaging, TRPA1 agonists allyl isothiocyanates (AITC) and hydrogen peroxide were observed to induce a transient Ca 2+ response in Caco‐2 cells, respectively. Moreover, TRPA1 knockdown in Caco‐2 cells resulted in the decreased expression of TJ proteins, ZO‐1 and Occludin, and in the increased paracellular permeabilities and the reduced TEER values of Caco‐2 monolayers in vitro. Furthermore, inhibition of TRPA1 by HC‐030031 in the confluent Caco‐2 cells caused the altered distribution and expression of TJ proteins, ZO‐1, Occludin, and Claudin‐3, and exacerbated the bacterial endotoxin lipopolysaccharide (LPS)‐induced damage to these TJ proteins and actin cytoskeleton. By contrast, AITC pretreatment restored the distribution and expression of these TJ proteins in the confluent Caco‐2 cells upon LPS challenge. Our results identify an unrecognized protective role of TRPA1 in host defense against an enteric bacterial pathogen by maintaining colonic epithelium barrier function, at least in part, via preserving the distribution and expression of TJ proteins in CECs.


  • Identification of MrgprD expression in mouse enteric neurons

    by Min Xu, Zhudi Zhang, Lei Lan

    Mas-related G protein-coupled receptor D (MrgprD) was first identified in small-diameter sensory neurons of mouse dorsal root ganglion (DRG). The role of MrgprD has been studied in somatosensation, especially in pain and itch response. We recently showed that MrgprD also participated in the modulation of murine intestinal motility. The treatment of MrgprD receptor agonist suppressed the spontaneous contractions in the isolated intestinal rings of mice, indicating the intrinsic expression of MrgprD in the murine gastrointestinal (GI) tract. Although the expression of Mrgprd in GI tract has been previously detected by the way of quantitative real-time PCR, the cell-type-specific expression of MrgprD in GI tract is no yet determined. Herein, we employed Mrgprd-tdTomato reporter mouse line and the whole-mount immunohistochemistry to observe the localization of MrgprD in the smooth muscle layers of ileum and colon. We show that tdTomato-positive cells colocalized with NeuN-immunostaining in the myenteric plexus in the whole-mount preparations of the ileum and the colon. Further immunohistochemistry using the commercially available MrgprD antibody revealed the expression of MrgprD in NeuN-labeled enteric neurons in the myenteric plexus. Our results demonstrate the expression of MrgprD in the enteric neurons in the murine GI tract, highlighting the implications of MrgprD in the physiology and pathophysiology of the GI tract.


  • Mas‐related G protein‐coupled receptor D is involved in modulation of murine gastrointestinal motility

    by Min Xu, Jia Li, Zhudi Zhang, Lin Liu, Fengyi Wan, Zongxiang Tang, Lei Lan

    New Findings: What is the central question of this study?The physiological function of Mas‐related G protein‐coupled receptor D (MrgprD) in gastrointestinal motility is unknown. The aim of this study was to assess the effects of MrgprD and its receptor agonists on murine gastrointestinal motility. What is the main finding and its importance?Mrgprd deficiency improved murine gastrointestinal motility in vivo but had no effects on the spontaneous contractions of murine intestinal rings ex vivo. Systemic administration of the MrgprD ligand, either β‐alanine or alamandine, delayed gastrointestinal transit in vivo and attenuated the spontaneous contractions of isolated intestinal rings ex vivo. Mas‐related G protein‐coupled receptor D (MrgprD) was first identified in sensory neurons of mouse dorsal root ganglion and has been demonstrated to be involved in sensations of pain and itch. Although expression of MrgprD has recently been found in the gastrointestinal (GI) tract, its physiological role in GI motility is unknown. To address this question, we used Mrgprd knockout (Mrgprd−/−) mice and MrgprD agonists to examine the effects of Mrgprd gene deletion and MrgprD signalling activation, respectively, on murine intestinal motility, both in vivo and ex vivo. We observed that the deletion of Mrgprd accelerated the transmission of charcoal through the mouse GI tract. But Mrgprd deficiency did not affect the mean amplitudes and frequencies of spontaneous contractions in ileum ex vivo. Colonic motor complexes in the proximal and the distal colon were recorded from wild‐type and Mrgprd−/− mice, but their control frequencies were not different. Moreover, in wild‐type mice, systemic administration of an MrgprD agonist, either β‐alanine or alamandine, delayed GI transit in vivo and suppressed spontaneous contractions in the ileum and colonic motor complexes in the colon ex vivo. Our results suggest that MrgprD and its agonist are involved in the modulation of GI motility in mice.


  • Does the Acupoint Specificity Exist? Evidence from Functional Neuroimaging Studies

    by Ke Qiu, Tao Yin, Xiaojuan Hong, Ruirui Sun, Zhaoxuan He, Xiaoyan Liu, Peihong Ma, Jie Yang, Lei Lan, Zhengjie Li, et al.

    Background: Using functional neuroimaging techniques to explore the central mechanism of acupoint specificity, the key of acupuncture theory and clinical practice, has attracted increasing attention worldwide. This review aimed to investigate the current status of functional neuroimaging studies on acupoint specificity and explore the potential influencing factors for the expression of acupoint specificity in neuroimaging studies.Methods: PubMed database was searched from January 1st, 1995 to December 31st, 2016 with the language restriction in English. Data including basic information, methodology and study results were extracted and analyzed from the eligible records.Results: Seventy-nine studies were finally enrolled. 65.8% of studies were performed in China, 73.4% of studies were conducted with healthy subjects, 77.2% of studies chose manual acupuncture as the intervention, 86.1% of studies focused on the instant efficacy and 89.9% of studies used functional magnetic resonance imaging as scanning technique. The average sample size was 16 per group. The comparison of verum acupoints and sham acupoints were the main body of acupoint specificity researches. 93.7% of studies obtained the positive results and favored the existence of acupoint specificity.Conclusion: This review affirmed the existence of acupoint specificity and deemed that the acupoint specificity was relative. Multiple factors such as participants, sample size, acupoint combinations, treatment courses, and types of acupoint could influence the expression of acupoint specificity.


  • Open Access

    The brain structure and function alterations in tension-type headache

    by Jun Zhou, Shirui Cheng, Han Yang, Lei Lan, Yijia Bd Chen, Guixing Xu, Zihan Yin, Zhengjie Li, Mailan Liu

    Objective: The aim of this systematic review and meta-analysis is to improve the understanding of the pathophysiology of tension-type headache (TTH), as well as propose avenues for future neuroimaging studies of TTH. Methods: From the inception dates to May 1, 2020, a systematic literature will search in Medline (Ovid SP), Embase (Ovid SP), Cochrane Central Register of Controlled Trials, Web of Science, and 4 Chinese databases without limitation on language or publication. Additionally, International Clinical Trials Registry Platform , reference lists, and relevant gray literatures will be searched. After screening of eligible references, included studies will be determined according to included criteria, and then data extraction and a methodological quality assessment with a customized checklist will be conducted. Each process will be independently implemented by 2 reviewers, any disagreement will be resolved by consensus to the third researcher. If the extracted data is feasible, anisotropic effect-size version of signed differential mapping will be conducted to perform the meta-analysis of the structural and functional brain alterations in TTH patients.


  • Open Access

    Mas-related G protein-coupled receptor D exacerbates inflammatory hyperalgesia by promoting NF-κB activation in dorsal root ganglia

    by Lei Lan, Miao Xu, Jia Li, Lin Liu, Min Xu, Chenxing Zhou, Lei Shen, Zongxiang Tang, Fengyi Wan

    Background Mas-related G protein–coupled receptor D (MrgprD) is mainly expressed in small-diameter sensory neurons of the dorsal root ganglion (DRG). Results from previous studies suggest that MrgprD participates in mechanical allodynia and nerve injury-induced neuropathic pain. However, it remains elusive whether and how MrgprD is involved in inflammatory pain. Methods we used a mouse model of inflammatory hyperalgesia established by intraperitoneal administration of lipopolysaccharide (LPS). The generation of neuroinflammation and inflammatory hyperalgesia were determined using animal behavioral tests, Western blotting, quantitative real-time PCR and ELISA assay. The expression levels of MrgprD were assessed by Western blotting. The involvements of MrgprD in the LPS-triggered neuroinflammation and inflammation-related signaling pathways were assessed by animal behavioral tests, Western blotting, immunohistochemistry, ELISA, and co-immunoprecipitation assays. Results The LPS injection induced an evident peripheral neuroinflammation and mechanical allodynia in the mice and increased MrgprD expression in the DRG. The LPS administration also augmented the proportion of MrgprD-expressing neurons in the lumbar 4 DRG. The LPS-induced hypersensitivities to mechanical and cold stimuli, but not to a heat stimulus, were substantially attenuated in Mrgprd- knockout mice compared with wildtype littermates. Mrgprd deletion suppressed the LPS-triggered activation of the NF-κB signaling pathway and attenuated LPS-induced up-regulation of proinflammatory cytokines. Moreover, ectopic overexpression of MrgprD in HEK293 cells stably expressing mouse toll-like receptor 4 (TLR4) markedly promoted the LPS-induced NF-κB activation and enhanced NF-κB’s DNA-binding activity. Furthermore, MrgprD physically interacted with TGF-β-activated kinase 1 (TAK1) and I-kappa-B-kinase (IKK) complexes in DRGs and macrophage-like RAW 264.7 cells, and MrgprD agonist treatment was sufficient to elicit the activation of NF-κB signaling, but not of mitogen-activated protein kinases (MAPKs) in RAW 264.7 cells. Conclusions Our findings demonstrate that MrgprD exacerbates LPS-induced inflammatory hyperalgesia by promoting canonical NF-κB activation, indicating that MrgprD could be a potential therapeutic target for managing NF-κB-mediated inflammation and inflammatory pain.

  • Open Access

    Expression and localization of MrgprD in mouse intestinal tract

    by Chenxing Zhou, Jia Li, Lin Liu, Zongxiang Tang, Fengyi Wan, Lei Lan

    MrgprD, a Mas-related G protein-coupled receptor, is initially identified in sensory neurons of mouse dorsal root ganglia (DRG) and has been suggested to participate in somatosensation. However, MrgprD has recently been found to be expressed outside the nervous system such as in aortic endothelia cells and neutrophils. In this study, we used immunohistochemistry to detect the expression and localization of MrgprD in mouse intestinal tract. The immunoreactivity (IR) of MrgprD was found in the smooth muscle layers of small intestine, colon and rectum. In addition, MrgprD IR was colocalized with F4/80-positive macrophages and CD3-positive T lymphocytes resident in the lamina propria of intestinal mucosa. MrgprD was also found to be expressed in primary peritoneal macrophages and splenic T lymphocytes. Furthermore, the presence of MrgprD mRNA and its protein was detected in murine macrophage-like RAW 264.7 and human T lymphocyte Jurkat cell lines. Our study shows, for the first time, the expression and localization of MrgprD in the intestinal tract and in macrophages and T lymphocytes, indicating the potential roles of MrgprD in intestinal mobility and immunity.


  • Open Access

    Facilitation of MrgprD by TRP‐A1 promotes neuropathic pain

    by Changming Wang, Leying Gu, Yonglan Ruan, Xiao Geng, Miao Xu, Niuniu Yang, Lei Yu, Yucui Jiang, Chan Zhu, Yan Yang, et al.

    Neuropathic pain remains a therapeutic challenge because of its complicated mechanisms. Mas‐related GPCR D (MrgprD) is specifically expressed in small‐diameter, nociceptive neurons of dorsal root ganglia (DRGs) and is implicated in pain modulation. However, the underlying mechanism of MrgprD involved in neuropathic pain remains elusive. In this study, we used behavioral experiments and physiologic examination methods to investigate the role of MrgprD in chronic constriction injury (CCI)–induced neuropathic pain. We found that MrgprD is necessary for the initiation of mechanical hypersensitivity and cold allodynia, but not for heat allodynia. Moreover, we demonstrated that transient receptor potential cation channel (TRP)‐A1 was the ion channel downstream of MrgprD, and the β‐alanine–induced calcium signal was attributed mostly to TRP‐A1 function. We further showed that PKA serves as a downstream mediator of β‐alanine–activated MrgprD signaling to activate TRP‐A1 in DRG neurons and in human embryonic kidney 293 cells, to coexpress MrgprD and TRP‐A1 plasmids. Finally, we found that the β‐alanine–induced pain behavior was increased, whereas the itching behavior was unchanged in CCI models compared with sham‐injured animals. Knockout of TRPA1 also attenuated the β‐alanine–induced pain behavior in CCI models. In conclusion, MrgprD is essential in cold allodynia in CCI‐induced neuropathic pain through the PKA–TRP‐A1 pathway. TRP‐A1 facilitates MrgprD to development of neuropathic pain. Our findings reveal a novel mechanism of neuropathic pain formation and highlight MrgprD as a promising drug target for the treatment of neuropathic pain.—Wang, C., Gu, L., Ruan, Y., Geng, X., Xu, M., Yang, N., Yu, L., Jiang, Y., Zhu, C., Yang, Y., Zhou, Y., Guan, X., Luo, W., Liu, Q., Dong, X., Yu, G., Lan, L., Tang, Z. Facilitation of MrgprD by TRP‐A1 promotes neuropathic pain. FASEB J. 33, 1360–1373 (2019). www.fasebj.org